Table 3

Decreased expression of genes restricted to myeloid lineage in Cited2−/− fetal liver and Linc-Kit+ cells at 13.5 dpc

Gene nameMicroarray
Real-time PCR
Fetal liverFetal liverLinc-Kit+ cells
Pre-pro proteinase3 −2.99 −2.78 ± 0.11 −2.9 ± 0.35 
Myeloperoxidase −2.53 −2.14 ± 0.02 −4.28 ± 0.16 
Neutrophil elastase −3.276 −3.275 ± 0.46 −5.77 ± 0.47 
Cathepsin G −2.738 −2.015 ± 0.12 −3.47 ± 0.07 
Eosinophil peroxidase −12.931 −6 ± 1.47 −6.12 ± 0.22 
Wnt5a −9.413 −4.68 ± 1.39 ND 
Gene nameMicroarray
Real-time PCR
Fetal liverFetal liverLinc-Kit+ cells
Pre-pro proteinase3 −2.99 −2.78 ± 0.11 −2.9 ± 0.35 
Myeloperoxidase −2.53 −2.14 ± 0.02 −4.28 ± 0.16 
Neutrophil elastase −3.276 −3.275 ± 0.46 −5.77 ± 0.47 
Cathepsin G −2.738 −2.015 ± 0.12 −3.47 ± 0.07 
Eosinophil peroxidase −12.931 −6 ± 1.47 −6.12 ± 0.22 
Wnt5a −9.413 −4.68 ± 1.39 ND 

Microarray data collected from Cited2−/− fetal liver (n=3) and Cited2+/+ littermate controls (n=3) were compared, and real-time PCR was performed to verify the expression of differentially expressed genes. HPRT was used as an internal control for real-time PCR, and the expression of each gene was normalized to HPRT and compared between Cited2−/− and Cited2+/+ littermate controls. The table shows mean (± SD) fold changes in Cited2−/− (n = 3-5) fetal liver at 14.5 dpc and Linc-Kit+ cells at 13.5 dpc after comparison with wild-type littermate controls (n = 3-5).

ND indicates not detected.

or Create an Account

Close Modal
Close Modal